[Liver biopsy in Slovakia]

Little is known about liver biopsy usage in Slovakia. Prior research has shown liver biopsy remains a gold standard for diagnosing diffuse liver diseases. However, regional data on its frequency and indications are sparse. No prior work had resolved the extent of liver biopsy procedures in Slovakia. That uncertainty drove the need for a survey-based study. The gap motivated researchers to collect data on biopsy techniques and complications. No prior work had resolved the role of biopsy in diagnosing viral hepatitis in this region. The lack of data on non-alcoholic steatohepatitis prevalence also remained unclear. This study aimed to clarify these unknowns.

The study aimed to determine how often liver biopsies were performed in Slovakia in 2001. Researchers sought to identify the most common indications for the procedure. They also wanted to assess the types of biopsy techniques used in the country. The goal included evaluating the frequency of complications associated with biopsies. The authors proposed to compare their findings with international literature. They intended to clarify the role of liver biopsy in diagnosing viral hepatitis. The study also aimed to examine the use of laparoscopic and trans-jugular methods. The purpose included assessing the safety profile of liver biopsies in this region.

The researchers conducted a correspondence study to gather data on liver biopsies in Slovakia. They collected information on the number of procedures performed in 2001. The study focused on diffuse liver diseases as the primary indication category. Data on biopsy techniques included percutaneous, laparoscopic, and trans-jugular methods. The authors requested details about complications and their frequency. They analyzed the most common diagnostic reasons for performing biopsies. The study compared the data with known international trends in hepatology. The authors emphasized the importance of collecting regional-specific data.

In 2001, 400 liver biopsies were performed in Slovakia for diffuse liver diseases. Of these, 296 were percutaneous, 82 laparoscopic, and 22 trans-jugular. Acute viral hepatitis was the most frequent indication for the procedure. Non-alcoholic steatohepatitis was reported as a rare diagnostic reason. The study found a complication rate of 0.00025%. No deaths were reported as a result of the biopsy procedures. The frequency of major complications was comparable to international data. The authors noted that the indications and techniques used aligned with global literature.

The authors concluded that liver biopsies in Slovakia were performed at a frequency consistent with global trends. The study found that acute viral hepatitis was the most common reason for the procedure. The use of laparoscopic and trans-jugular techniques was less common than percutaneous methods. The complication rate remained very low, with no reported deaths. The authors proposed that the safety profile matched international standards. They emphasized the importance of liver biopsy in diagnosing diffuse liver diseases. The data supported the continued use of biopsy as a reliable diagnostic tool. The findings suggested that Slovakia’s practices align with broader hepatology guidelines.